Organogenesis Holdings (ORGO) Goodwill & Intangibles (2017 - 2026)
Organogenesis Holdings' (ORGO) quarterly Goodwill & Intangibles came in at $32.2 million in Q1 2026, down 20.27% year-on-year from $40.4 million in Q1 2025, and down 15.05% quarter-over-quarter from $37.9 million in Q4 2025.
Organogenesis Holdings (ORGO) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $32.2 million for Q1 2026.
- On a quarterly basis, Goodwill & Intangibles fell 20.27% year-over-year to $32.2 million in Q1 2026; TTM through Mar 2026 was $32.2 million, a 20.27% decrease from a year earlier, with the FY2025 full-year figure at $37.9 million, down 8.06% from the prior year.
- Goodwill & Intangibles declined to $32.2 million in Q1 2026 per ORGO's latest filing, from $37.9 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $53.2 million in Q1 2022 and bottomed at $32.2 million in Q1 2026.
- The 5-year median for Goodwill & Intangibles is $43.7 million (2024), against an average of $44.1 million.
- Across the five-year window, Goodwill & Intangibles decreased 7.62% in 2024 and slipped 20.27% in 2026, its largest moves.
- Year by year, Goodwill & Intangibles stood at $49.6 million in 2022, then declined by 9.92% to $44.6 million in 2023, then fell by 7.62% to $41.2 million in 2024, then dropped by 8.06% to $37.9 million in 2025, then fell by 15.05% to $32.2 million in 2026.
- Per Business Quant, the three latest ORGO Goodwill & Intangibles figures stand at $32.2 million (Q1 2026), $37.9 million (Q4 2025), and $38.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.21 Mn |
| Dec 31, 2025 | 37.92 Mn |
| Sep 30, 2025 | 38.72 Mn |
| Jun 30, 2025 | 39.56 Mn |
| Mar 31, 2025 | 40.40 Mn |
| Dec 31, 2024 | 41.24 Mn |
| Sep 30, 2024 | 42.07 Mn |
| Jun 30, 2024 | 42.91 Mn |
| Mar 31, 2024 | 43.74 Mn |
| Dec 31, 2023 | 44.64 Mn |
| Sep 30, 2023 | 45.87 Mn |
| Jun 30, 2023 | 47.10 Mn |
| Mar 31, 2023 | 48.33 Mn |
| Dec 31, 2022 | 49.56 Mn |
| Sep 30, 2022 | 50.78 Mn |
| Jun 30, 2022 | 52.00 Mn |
| Mar 31, 2022 | 53.22 Mn |
| Dec 31, 2021 | 54.45 Mn |
| Sep 30, 2021 | 55.67 Mn |
| Jun 30, 2021 | 56.91 Mn |